Subscribe to RSS
DOI: 10.1055/s-2007-979214
Propofol in Office-Based Plastic Surgery
Publication History
Publication Date:
29 May 2007 (online)

ABSTRACT
Propofol is the nearly ideal agent for office-based plastic surgery. Among all anesthetic agents, only propofol has the ability to elicit happiness in this special group of patients. Cosmetic surgery patients will tolerate discomfort in preference to postoperative nausea and vomiting. Propofol is a powerful antiemetic agent. Patient safety will not be optimized unless the person responsible for the administration of propofol has airway management skills. Dedicated anesthesia providers are highly skilled in airway management. Although the short half-life of propofol is seductive for a fast-acting, rapid emerging anesthetic, interindividual differences in propofol response make measurement of the target organ (i.e., the brain) with a bispectral index (BIS) monitor very important. BIS levels < 45 for > 1 hour are associated with increased 1-year anesthesia mortality thought to be associated with an inflammatory response. The only currently available way to avoid overmedicating with propofol is to monitor with a level of consciousness monitor like BIS.
KEYWORDS
Propofol - anesthesia - BIS monitor - office-based plastic surgery - ketamine
REFERENCES
- 1 Macario A, Weinger M, Truong P et al.. Which clinical outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists. Anesth Analg. 1999; 88 1085
- 2 Macario A, Weinger M, Carney K et al.. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg. 1999; 89 652
- 3 White P F. Prevention of postoperative nausea and vomiting-a multimodal solution to a persistent problem. N Engl J Med. 2004; 350 2511
- 4 Scuderi P E, James R L, Harris L et al.. Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg. 2000; 91 1408
- 5 Apfel C C, Korttila K, Abdalla M et al.. A factorial trial of six interventions for the prevention of PONV. N Engl J Med. 2004; 350 2441
-
6 Friedberg B L.
Propofol ketamine anesthesia for cosmetic surgery in the office suite . In: Osborne I Anesthesia for outside the operating room. International Anesthesiology Clinics. Baltimore; Lippincott Williams & Wilkins 2003 - 7 Friedberg B L. Minimally invasive anesthesia for minimally invasive surgery. Outpatient Surgery Magazine. 2004; 2 57
- 8 Friedberg B L, Sigl J C. Bispectral (BIS) index monitoring decreases propofol usage in propofol-ketamine office based anesthesia. Anesth Analg. 1999; 88 S54
- 9 Friedberg B L, Sigl J C. Clonidine premedication decreases propofol consumption during bispectral (BIS) index monitored propofol-ketamine technique for office based surgery. Dermatol Surg. 2000; 26 848
- 10 Court M H, Duan S X, Hesse L M et al.. Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes. Anesthesiol. 2001; 94 110
-
11 Friedberg B L.
Propofol ketamine with bispectral index (BIS) monitoring . In: Friedberg BL Anesthesia in cosmetic surgery. New York, NY; Cambridge University Press 2007 1 - 12 Monk T G, Saini V, Weldon B C et al.. Anesthetic management and one-year mortality after non-cardiac surgery. Anesth Analg. 2005; 100 4
- 13 Flaishon R, Windsor A, Sigl J et al.. Recovery of consciousness after thiopental or propofol. Anesthesiol. 1997; 86 613
- 14 Aspect Medical Systems. http://Available at: www.aspectms.com/resources/bibliographies Acessed: April 11, 2007
- 15 Kersssens C, Sebel P. Relationship between hypnotic depth and post-operative C- reactive protein levels. Anesthesiol. 2006; 105 A578
Barry L FriedbergM.D.
Clinical Assistant Professor in Anesthesia, Volunteer Faculty, Department of Anesthesia, University of Southern California
3535 E. Coast Hwy, PMB 103, Corona del Mar, CA 92625-2104